Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M M Samama

Showing results (61-70 of 184) with videos related to

Pageof 19
Sort By:
Annales De Biologie Clinique|October 7, 2000
[Follow-up of the treatment by direct thrombin inhibitors: activated partial thromboplastin time or ecarin clotting time]A Kher, I Gouin, M M Samama
Archives Des Maladies Du Coeur Et Des Vaisseaux|January 1, 1995
[Current biological surveillance of oral anticoagulant treatment]G Helft, A Vacheron, M M Samama
Journal Des Maladies Vasculaires|April 13, 2012
Pro- and anti-angiogenic agentsA Bridoux, S A Mousa, M-M Samama
Drugs|January 1, 1996
New data on the pharmacology of heparin and low molecular weight heparinsM M Samama, L Bara, I Gouin-Thibault
Thrombosis Research|October 15, 1992
A comparative study of recombinant hirudin and standard heparin in the Wessler modelL Bara, M F Bloch, M M Samama
Thrombosis Research|June 1, 1990
The inhibition of intrinsic prothrombinase and its generation by heparin and four derivatives in prothrombin poor plasmaA V Bendetowicz, L Bara, M M Samama
Journal Des Maladies Vasculaires|January 6, 2010
[Pregnancy and venous thromboembolism. North-American and European guidelines. American College of Chest Physicians]J Conard, M H Horellou, M M Samama, et al.
La Ricerca in Clinica E in Laboratorio|October 1, 1989
Screening for inherited thrombotic disordersJ Conard, M H Horellou, M M Samama
Infectious Diseases in Obstetrics and Gynecology|January 1, 1997
Laboratory diagnosis of antiphospholipid antibodiesM M Samama, M H Horellou, J Conard
Haemostasis|March 1, 1994
Mechanisms for the antithrombotic activity in man of low molecular weight heparins (LMWHs)M M Samama, L Bara, G T Gerotziafas
Pageof 19

Showing results (61-70 of 184) with videos related to

Sort By:
Pageof 19
Annales De Biologie Clinique|October 7, 2000
[Follow-up of the treatment by direct thrombin inhibitors: activated partial thromboplastin time or ecarin clotting time]A Kher, I Gouin, M M Samama
Archives Des Maladies Du Coeur Et Des Vaisseaux|January 1, 1995
[Current biological surveillance of oral anticoagulant treatment]G Helft, A Vacheron, M M Samama
Journal Des Maladies Vasculaires|April 13, 2012
Pro- and anti-angiogenic agentsA Bridoux, S A Mousa, M-M Samama
Drugs|January 1, 1996
New data on the pharmacology of heparin and low molecular weight heparinsM M Samama, L Bara, I Gouin-Thibault
Thrombosis Research|October 15, 1992
A comparative study of recombinant hirudin and standard heparin in the Wessler modelL Bara, M F Bloch, M M Samama
Thrombosis Research|June 1, 1990
The inhibition of intrinsic prothrombinase and its generation by heparin and four derivatives in prothrombin poor plasmaA V Bendetowicz, L Bara, M M Samama
Journal Des Maladies Vasculaires|January 6, 2010
[Pregnancy and venous thromboembolism. North-American and European guidelines. American College of Chest Physicians]J Conard, M H Horellou, M M Samama, et al.
La Ricerca in Clinica E in Laboratorio|October 1, 1989
Screening for inherited thrombotic disordersJ Conard, M H Horellou, M M Samama
Infectious Diseases in Obstetrics and Gynecology|January 1, 1997
Laboratory diagnosis of antiphospholipid antibodiesM M Samama, M H Horellou, J Conard
Haemostasis|March 1, 1994
Mechanisms for the antithrombotic activity in man of low molecular weight heparins (LMWHs)M M Samama, L Bara, G T Gerotziafas
Pageof 19